Last news
Prosper Family Office Opens New Office in Tsim Sha Tsui

Prosper Family Office Opens New Office in Tsim Sha Tsui

Ribbon cut by Dr Justin Chiu, Executive Director of CK Asset Holdings Limited; Miss Lai-Chong Au, Group Chief Executive Officer of Delta Asia Financial Group; and Dr Cartier Lam, former Executive Director & Chief Executive of The Bank of East...

Yunji to Report First Half 2026 Financial Results on August 20, 2026

Yunji to Report First Half 2026 Financial Results on August 20, 2026

HANGZHOU, China, Aug. 13, 2026 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that it plans to release its unaudited interim financial results before the...

DoGo Power Wins EUPD Research's 2026 Top Innovation Award in Europe

DoGo Power Wins EUPD Research's 2026 Top Innovation Award in Europe

BONN, Germany, Aug. 13, 2026 /PRNewswire/ -- DoGo Power has been presented with the 2026 Top Innovation Award by EUPD Research, a leading European research authority, for its fully self-developed 4S grid-forming energy storage technology. The honor...

IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics

IASO Biotechnology Announces Acquisition of Singapore-Based Cell Therapy Company MediSix Therapeutics

NANJING, China, SHANGHAI and SINGAPORE, Aug. 13, 2026 /PRNewswire/ -- IASO Biotechnology ("IASO Bio") today announced the completion of its acquisition of MediSix Therapeutics ("MediSix"), a Singapore-based immune cell engineering and cell therapy...

Lufax to Announce Second Quarter 2026 Financial Results on August 18, 2026

Lufax to Announce Second Quarter 2026 Financial Results on August 18, 2026

SHANGHAI, Aug. 13, 2026 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that it plans to release its second quarter 2026...

Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona

Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona

NEW YORK and SUZHOU, China, Aug. 13, 2026 /PRNewswire/ -- Accro Bioscience, a clinical-stage biotechnology company pioneering the development of novel therapeutics for immune mediated diseases, today announced that it will present efficacy and...

Tourism Authority of Thailand Drives Low-Carbon Transformation Through the CF-Hotels Initiative

Tourism Authority of Thailand Drives Low-Carbon Transformation Through the CF-Hotels Initiative

SINGAPORE, Aug. 13, 2026 /PRNewswire/ -- The Tourism Authority of Thailand (TAT) has earned recognition under the Green Leadership category at the Asia Responsible Enterprise Awards (AREA) 2026, organized by Enterprise Asia, for its outstanding...

Noah to Report Second Quarter and Half Year 2026 Unaudited Financial Results on August 25, 2026

Noah to Report Second Quarter and Half Year 2026 Unaudited Financial Results on August 25, 2026

SINGAPORE, Aug. 13, 2026 /PRNewswire/ -- Noah Holdings Limited (the "Company" or "Noah") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive advisory services on global investment and asset...

1 2 3 4 5 6 7 8 9 10 ... 5249
menu
menu